{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:08:16Z","timestamp":1790633296635,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israeli Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytometry Part B Clinical"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cellular aggregation is a physiological response of lymphocytes to various extracellular stimuli. Currently, lymphocytes aggregation is only evaluated qualitatively or by semiquantitative methods. In this study, we assessed the capacity of flow cytometry to measure lymphocytes aggregation in a quantitative, accurate, and reproducible manner, and examined the significance of aggregation responses in various lymphoproliferative diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Extracellular triggers such as anti\u2010CD19 antibodies or phorbol ester were utilized to induce lymphoid cells aggregation in a concentration dependent manner. Aggregation was quantified by flow cytometry based on the forward or side scatter (SSC), or by dark\u2010field SSC of aggregates measured by ImageStreamX. Accuracy, reproducibility, and limitations of the methodology were evaluated. Aggregation responses were measured in various types of lymphoproliferative diseases, and correlated with immunophenotyping and IGHV mutational status in chronic lymphocytic leukemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Lymphoid aggregates provoked by extracellular stimuli elevate the forward and SSC signals relatively to the number of cells in each event. Aggregation responses vary among different types of lymphoproliferative diseases. Moreover, elevated levels of CD19\u2010induced aggregation are associated with aberrant chronic lymphocytic leukemia characteristics, but not with IGHV mutational status of the disease<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We have demonstrated that flow cytometry can provide accurate and reproducible measurement of both primary as well as T and B cell lines aggregation in response to extracellular stimuli. The use of quantitative evaluation of activation driven or other cellular aggregation may provide an analytical tool to elucidate biochemical and molecular mechanisms associated with lymphoproliferative diseases. \u00a9 2015 International Clinical Cytometry Society<\/jats:p><\/jats:sec>","DOI":"10.1002\/cyto.b.21263","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T07:40:24Z","timestamp":1434526824000},"page":"257-266","source":"Crossref","is-referenced-by-count":11,"title":["Measurement of lymphocyte aggregation by flow cytometry\u2013physiological implications in chronic lymphocytic leukemia"],"prefix":"10.1002","volume":"90","author":[{"given":"Nili","family":"Dezorella","sequence":"first","affiliation":[{"name":"The Department of Hematology Tel Aviv Sourasky Medical Center  Tel\u2010Aviv Israel 64239"},{"name":"Sackler Faculty of Medicine Tel Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigi","family":"Kay","sequence":"additional","affiliation":[{"name":"The Department of Hematology Tel Aviv Sourasky Medical Center  Tel\u2010Aviv Israel 64239"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana","family":"Baron","sequence":"additional","affiliation":[{"name":"The Department of Hematology Tel Aviv Sourasky Medical Center  Tel\u2010Aviv Israel 64239"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Shapiro","sequence":"additional","affiliation":[{"name":"The Department of Hematology Tel Aviv Sourasky Medical Center  Tel\u2010Aviv Israel 64239"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Porat","sequence":"additional","affiliation":[{"name":"The Biological Services Department Life Sciences Faculty, Weizmann Institute of Science Rehovot Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varda","family":"Deutsch","sequence":"additional","affiliation":[{"name":"The Department of Hematology Tel Aviv Sourasky Medical Center  Tel\u2010Aviv Israel 64239"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Herishanu","sequence":"additional","affiliation":[{"name":"The Department of Hematology Tel Aviv Sourasky Medical Center  Tel\u2010Aviv Israel 64239"},{"name":"Sackler Faculty of Medicine Tel Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben\u2010Zion","family":"Katz","sequence":"additional","affiliation":[{"name":"The Department of Hematology Tel Aviv Sourasky Medical Center  Tel\u2010Aviv Israel 64239"},{"name":"Sackler Faculty of Medicine Tel Aviv University Tel\u2010Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.05.017"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","unstructured":"FranciottaD Columba\u2010CabezasS AndreoniL RavagliaS JariusS RomagnoloS TavazziE BergamaschiR ZardiniE AloisiF et al.Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases.J Neuroimmunol2008;200:125\u2013128.","DOI":"10.1016\/j.jneuroim.2008.06.004"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","unstructured":"HeiderKH KieferK ZenzT VoldenM StilgenbauerS OstermannE BaumA LamcheH KupcuZ JacobiA et al.A novel Fc\u2010engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B\u2010cell malignancies.Blood2011;118:4159\u20134168.","DOI":"10.1182\/blood-2011-04-351932"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","unstructured":"AlduaijW IvanovA HoneychurchJ CheadleEJ PotluriS LimSH ShimadaK ChanCH TuttA BeersSA et al.Novel type II anti\u2010CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin\u2010dependent lysosome\u2010mediated cell death in B\u2010cell malignancies.Blood2011;117:4519\u20134529.","DOI":"10.1182\/blood-2010-07-296913"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400883"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","unstructured":"HerishanuY KayS DezorellaN BaronS Hazan\u2010HalevyI PoratZ TrestmanS PerryC BraunsteinR DeutschV et al.Divergence in CD19\u2010mediated signaling unfolds intraclonal diversity in chronic lymphocytic leukemia which correlates with disease progression.J Immunol2013;190:784\u2013793.","DOI":"10.4049\/jimmunol.1200615"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.4.1407"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018224108"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","unstructured":"ScielzoC BertilaccioMT SimonettiG DagklisA ten HackenE FaziC MuzioM CaiolfaV KitamuraD RestucciaU et al.HS1 has a central role in the trafficking and homing of leukemic B cells.Blood2010;116:3537\u20133546.","DOI":"10.1182\/blood-2009-12-258814"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M704699200"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201243203"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.026294"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.5858\/2006-130-680-CACFCI","article-title":"9color and 10\u2010color flow cytometry in the clinical laboratory","volume":"130","author":"Wood B.","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_6_15_1","unstructured":"HallekM ChesonBD CatovskyD Caligaris\u2010CappioF DighieroG DohnerH HillmenP KeatingMJ MontserratE RaiKR et al.Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute\u2010Working Group 1996 guidelines.Blood2008;111:5446\u20135456."},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","unstructured":"HerishanuY KayS JoffeE Ben\u2010EzraJ BaronS RotmanR BraunsteinR DezorellaN PolliackA NaparstekE et al.Integration of automated morphological features resolves a distinct group of atypical chronic lymphocytic leukemias with chromosomal aberrations.Leuk Res2014;38:484\u2013489.","DOI":"10.1016\/j.leukres.2014.01.008"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","unstructured":"KalinaT Flores\u2010MonteroJ van derVeldenVH Martin\u2010AyusoM BottcherS RitgenM AlmeidaJ LhermitteL AsnafiV MendoncaA et al.EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.Leukemia2012;26:1986\u20132010.","DOI":"10.1038\/leu.2012.122"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb04203.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-007-9038-7"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb04336.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.42.6.567"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.4049\/jimmunol.160.9.4208","article-title":"Differential requirements for LFA\u20101 binding to ICAM\u20101 and LFA\u20101\u2010mediated cell aggregation","volume":"160","author":"Petruzzelli L","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2007.03.001"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21090"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20078"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20129"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22219"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","unstructured":"MorganE VarroR SepulvedaH EmberJA ApgarJ WilsonJ LoweL ChenR ShivrajL AgadirAand others.Cytometric bead array: a multiplexed assay platform with applications in various areas of biology.Clin Immunol2004;110:252\u201366.","DOI":"10.1016\/j.clim.2003.11.017"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","unstructured":"DekkingEH van derVeldenVH VarroR WaiH BottcherS KnebaM SonneveldE KoningA BoeckxN VanPoeckeN et al.Flow cytometric immunobead assay for fast and easy detection of PML\u2010RARA fusion proteins for the diagnosis of acute promyelocytic leukemia.Leukemia2012;26:1976\u20131985.","DOI":"10.1038\/leu.2012.125"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22049"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.666542"},{"key":"e_1_2_6_32_1","doi-asserted-by":"crossref","unstructured":"RawstronAC ShanafeltT LanasaMC LandgrenO HansonC OrfaoA HillmenP GhiaP.Different biology and clinical outcome according to the absolute numbers of clonal B\u2010cells in monoclonal B\u2010cell lymphocytosis (MBL).Cytometry B Clin Cytom2010;78Suppl 1:S19\u201323.","DOI":"10.1002\/cyto.b.20533"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909093723"},{"key":"e_1_2_6_34_1","doi-asserted-by":"crossref","unstructured":"CrielA VerhoefG VlietinckR MecucciC BillietJ MichauxL MeeusP LouwagieA VanOrshovenA VanHoofA et al.Further characterization of morphologically defined typical and atypical CLL: a clinical immunophenotypic cytogenetic and prognostic study on 390 cases.Br J Haematol1997;97:383\u2013391.","DOI":"10.1046\/j.1365-2141.1997.402686.x"}],"container-title":["Cytometry Part B: Clinical Cytometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcyto.b.21263","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cyto.b.21263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T20:59:22Z","timestamp":1696539562000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cyto.b.21263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1002\/cyto.b.21263"],"URL":"https:\/\/doi.org\/10.1002\/cyto.b.21263","archive":["Portico"],"relation":{},"ISSN":["1552-4949","1552-4957"],"issn-type":[{"value":"1552-4949","type":"print"},{"value":"1552-4957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}